Ascend Advanced Therapies, an end-to-end gene therapy development partner, has acquired the CMC team and site in Alachua, FL from Beacon Therapeutics—thereby adding an operational good manufacturing practice (GMP) facility, process and analytical development capabilities, and additional experts to the Ascend team. The acquisition also includes a long-term partnership with Beacon to continue manufacturing its products for clinical and commercial use, securing product supply for Beacon and enablin...